These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23785839)

  • 21. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug discovery in autism: the need for a developmental context.
    Willemsen-Swinkels SH; Buitelaar JK
    Drug Discov Today; 2004 Jun; 9(11):473. PubMed ID: 15149620
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lofexidine in hyperactive and impulsive children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1396-7. PubMed ID: 12447025
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study.
    Charnsil C
    J Atten Disord; 2011 Nov; 15(8):684-9. PubMed ID: 20686100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
    Chez MG; Aimonovitch M; Buchanan T; Mrazek S; Tremb RJ
    J Child Neurol; 2004 Mar; 19(3):165-9. PubMed ID: 15119476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder.
    Lambrey S; Falissard B; Martin-Barrero M; Bonnefoy C; Quilici G; Rosier A; Guillin O
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):79-80. PubMed ID: 20166802
    [No Abstract]   [Full Text] [Related]  

  • 28. [Infantile autism and drug therapy].
    Kehrer HE
    Bibl Psychiatr; 1978; (157):91-7. PubMed ID: 348194
    [No Abstract]   [Full Text] [Related]  

  • 29. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism.
    Giannotti F; Cortesi F; Cerquiglini A; Bernabei P
    J Autism Dev Disord; 2006 Aug; 36(6):741-52. PubMed ID: 16897403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the treatment with fenfluramine of autism in children].
    de Villard R; Ceillier-Hoppenot B; Flachaire E; Dalery J; Rebaud B; Maillet J; Revol O; Mamelle JC; Quincy C
    Pediatrie; 1988; 43(8):703-8. PubMed ID: 3065724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untoward effects of fenfluramine in autistic children.
    Realmuto GM; Jensen J; Klykylo W; Piggott L; Stubbs G; Yuwiler A; Geller E; Freeman BJ; Ritvo E
    J Clin Psychopharmacol; 1986 Dec; 6(6):350-5. PubMed ID: 3543069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy to control behavioral symptoms in children with autism.
    Doyle CA; McDougle CJ
    Expert Opin Pharmacother; 2012 Aug; 13(11):1615-29. PubMed ID: 22550944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low-dose levodopa therapy of autistic disorder: evaluation of clinical effectiveness].
    Sugiyama N; Sugie H; Igarashi Y; Ito M; Fukuda T
    No To Hattatsu; 1998 Jan; 30(1):51-5. PubMed ID: 9436408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder.
    Steingard RJ; Zimnitzky B; DeMaso DR; Bauman ML; Bucci JP
    J Child Adolesc Psychopharmacol; 1997; 7(1):9-15. PubMed ID: 9192538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of drug effects in autistic children.
    Cohen IL; Anderson LT; Campbell M
    Psychopharmacol Bull; 1978 Oct; 14(4):68-70. PubMed ID: 704767
    [No Abstract]   [Full Text] [Related]  

  • 38. Paliperidone for irritability in autistic disorder.
    Stigler KA; Erickson CA; Mullett JE; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):75-8. PubMed ID: 20166801
    [No Abstract]   [Full Text] [Related]  

  • 39. Mirtazapine treatment in a subject with autistic disorder and fetishism.
    Coskun M; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):206-9. PubMed ID: 18439117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.